Article
Rickettsia parkeriandCandidatusRickettsia andeanae in Tick of theAmblyomma maculatumGroup, Mexico
5 Mar 2019
Abstract excerpt
several years after initial infection (1). Issues with primaquine (i.e., CYP2D6-poor metabolizers or hemolysis risk in patients with glucose-6-phosphate dehydrogenase deficiency) complicate treatment of dormant hypnozoites that cause relapse (1). A new treatment, tafenoquine, which still causes hemolysis in glucose-6-phosphate dehydrogenase deficiency, was recently approved in the United States as a single dose...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
